title: Recurrent Campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review.
abstract: X-linked agammaglobulinemia (XLA) is a primary immune deficiency disease with a B-cell defect. We present the first XLA patient who had recurrent Campylobacter lari bacteremia. High dose intravenous immunoglobulin combined with azithromycin once per week, and a complete avoidance of bacterial reservoirs may be helpful for the prevention of C. lari bacteremia.
authors.affiliation: Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. siojr@mahidol.ac.th
authors.forename: Orathai
authors.initials: O
authors.lastname: Jirapongsananuruk
authors.forename: Kalaya
authors.initials: K
authors.lastname: Wanotayan
authors.forename: Wanatpreeya
authors.initials: W
authors.lastname: Phongsamart
authors.forename: Kulkanya
authors.initials: K
authors.lastname: Chokephaibulkit
authors.forename: Nualanong
authors.initials: N
authors.lastname: Visitsunthorn
authors.forename: Voravich
authors.initials: V
authors.lastname: Luangwedchakarn
authors.forename: Nirun
authors.initials: N
authors.lastname: Vanprapar
authors.forename: Pakit
authors.initials: P
authors.lastname: Vichyanond
mesh_terms: D000293:Adolescent; D000361:Agammaglobulinemia / Q000150:complications* / Q000382:microbiology; D017963:Azithromycin / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D044863:Campylobacter lari; D004359:Drug Therapy, Combination; D040181:Genetic Diseases, X-Linked / Q000150:complications* / Q000382:microbiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D012008:Recurrence; D012852:Sinusitis / Q000209:etiology / Q000382:microbiology
chemical_list: D016756:Immunoglobulins, Intravenous; D017963:Azithromycin